Neonatal Antiepileptic Medication Treatment Patterns: A Decade of Change

Autor: Hibo H. Abdi, Lina Yossef, Laurel A. Slaughter, Jonathan L. Slaughter, Pablo J. Sánchez, Patricia B. Reagan, Angela Firestine, Vi T. Le
Rok vydání: 2019
Předmět:
Zdroj: Am J Perinatol
ISSN: 1098-8785
Popis: Objective This study aims to describe the frequency and characteristics of anticonvulsant medication treatments initiated in the neonatal period. Study Design We analyzed a cohort of neonates with a seizure diagnosis who were discharged from institutions in the Pediatric Health Information System between 2007 and 2016. Adjusted risk ratios and 95% confidence intervals for characteristics associated with neonatal (≤ 28 days postnatal) anticonvulsant initiation were calculated via modified Poisson regression. Results A total of 6,245 infants from 47 institutions were included. There was a decrease in both phenobarbital initiation within the neonatal period (96.9 to 91.3%, p = 0.015) and continuation at discharge (90.6 to 68.6%, p Conclusion Phenobarbital remains the most widely used neonatal seizure treatment. Levetiracetam is increasingly used as a second line therapy. Increasing levetiracetam use indicates a need for additional study to determine its effectiveness in reducing seizure burden and improving long-term outcomes.
Databáze: OpenAIRE